Conferences

Conference Year
Conference Month
 

Upcoming MDPI Conferences (3)

24–26 April 2024 4th MMCS: Harnessing the Power of New Drug Modalities

Barcelona, Spain

We are delighted to announce the upcoming 4th Molecules Medicinal Chemistry Symposium – Harnessing the Power of New Drug Modalities (MMCS2024), which will take place in Barcelona, Spain, from April 24th to 26th, 2024.

Organized by MDPI, the publisher of the open-access journal Molecules, this conference follows the successful MMCS2019 and MMCS2022 editions, maintaining the highly appreciated three-day format to accommodate a diverse range of contributions and a large audience interested in the impact that the emergence of new drug modalities is having in drug discovery. MMCS2024's thematic sessions will revolve around photoactivatable drugs, candidates that hit RNA and epigenetic targets, and covalent modifiers. The use of these and other more classical approaches for the development of new anti-cancer agents and other medicinal chemistry projects will also be covered.

Each session will include two distinguished invited speakers who will share their insights, alongside selected oral communications. Poster presentations and social events will further enrich the program.

Our exciting lineup of invited speakers include:

  • Prof. Dr. Xavier Barril, Faculty of Pharmacy, University of Barcelona, Spain
  • Prof. Dr. Paul Brennan, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, UK
  • Prof. Dr. Luc Brunsveld, Laboratory of Chemical Biology, Eindhoven University of Technology, The Netherlands
  • Dr. Maria Duca, Institute of Chemistry of Nice, Université Côte d'Azur, France
  • Prof. Dr. Arun K. Ghosh, Department of Chemistry; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, USA
  • Prof. Dr. Pau Gorostiza, ICREA, Institute for Bioengineering of Catalonia (IBEC), CIBER-bbn, Spain
  • Prof. Dr. Anna K. H. Hirsch, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany
  • Prof. Dr. Swen Hoelder, The Institute of Cancer Research, London, UK
  • Prof. Dr. Xiaoguang Lei, College of Chemistry and Molecular Engineering, Peking University, China
  • Dr. Alessandra Magistrato, Istituto Officina dei Materiali (IOM) at International School of Advanced Studies (SISSA), Italy
  • Prof. Dr. Wiktor Szymanski, Groningen Research Institute of Pharmacy, University of Groningen, The Netherlands
  • Prof. Dr. Matthias P. Wymann, Department of Biomedicine, University of Basel, Switzerland

Submit your abstract here!

Register to the conference here!

We look forward to welcoming you to Barcelona in April, a perfect time to visit for its delightful weather, vibrant spring atmosphere, and a wide array of cultural and outdoor activities that will provide an inspiring backdrop for our conference.

Prof. Diego Muñoz-Torrero
Editor-in-Chief of the Medicinal Chemistry Section of Molecules
MMCS2024 Chair

Prof. Simona Collina
Editorial board of the Medicinal Chemistry Section of Molecules
MMCS2024 Co-Chair

https://bit.ly/3R4N8d8

24 April 2024 Pharmaceutics Webinar | Where Are We Now and Where Is Antimicrobial Therapy Headed?, 24 April 2024

Online

A welcome message from Dr. Fábio Fernandes, the webinar chair:

Dear Colleagues,

It is my pleasure to welcome each of you to this webinar! As Chair, I am pleased to see the convergence of research aimed at understanding “Where Are We Now and Where Is Antimicrobial Therapy Headed?”.

Antimicrobial resistance poses more of a concern today than ever before. Our collaborative efforts, insights, and inventions are critical in navigating this difficult world. This meeting provides an opportunity for us to exchange ideas, examine breakthroughs, and plot a course for a future in which effective antimicrobial therapy remains a cornerstone of modern medicine.

Our schedule for this webinar is packed with interesting talks, from antimicrobial dendrimer and lipid nanoparticles to the regulation of biofilms by RNA. I encourage all of you to actively engage in the sessions, contribute your views, and take advantage of the opportunity to network with our panel of experts and other researchers.

Again, welcome to this webinar!

Dr. Fábio Fernandes

Date: 24 April 2024 10.00 a.m. CEST | 4:00 a.m. EDT | 4:00 p.m. CST Asia
Webinar ID: 841 5162 0647
Webinar Secretariat: journal.webinar@mdpi.com
Webinar Announcement: https://sciforum.net/event/Pharmaceutics-3

Register for free:

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we will inform you when the recording is available.

Speaker/Presentation Time in CEST Time in EDT
Dr. Fábio Fernandes
Chair Introduction
10:00 a.m.–10:10 a.m. 4:00a.m.–4:10 p.m.
Dr. Sandra Pinto
Introducing the topic: “Where Are We Now and Where Is Antimicrobial Therapy Headed?”
10:10 a.m.–10:30 a.m. 4:10 a.m.–4:30 a.m.
Dr. Maria Manuela Gaspar
The Key Role of Liposomes as Delivery Systems for the Management of Infectious Diseases
10:30 a.m.–10:50 a.m. 4:30a.m.–4:50 a.m.
Dr. Vasco Bonifácio
Polyurea Pharmadendrimers: The Next Generation of Antimicrobials
10:50 a.m.–11:10 a.m. 4:50 a.m.–5:10 a.m.
Dr. Vânia Pobre
How RNA Regulators Influence Biofilm Formation
11:10 a.m.–11:30 a.m. 5:10 a.m.–5:30 a.m.
Q&A Session 11:30 a.m.–12:00 p.m. 5:30 a.m.–6:00 a.m.
Dr. Fábio Fernandes
Closing of Webinar
12:00 p.m.–12:05 p.m. 6:00 a.m.–6:05 a.m.

Webinar Chair and Keynote Speakers:

  • Fábio Fernandes (Chair), Institute for Bioengineering and Biosciences (IBB) and Associate Laboratory, Institute for Health and Bioeconomy (i4HB), Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal;
  • Sandra Pinto, Institute for Bioengineering and Biosciences (IBB) and Associate Laboratory, Institute for Health and Bioeconomy (i4HB), Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal;
  • Maria Manuela Gaspar, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal;
  • Vasco Bonifácio, Institute for Bioengineering and Biosciences (IBB) and Associate Laboratory, Institute for Health and Bioeconomy (i4HB), Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal;
  • Vânia Pobre, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa (ITQB NOVA), Oeiras, Portugal.

Relevant Special Issue:

Where Are We Now and Where Is Antimicrobial Therapy Headed?
Guest Editor: Dr. Sandra N. Pinto
Deadline for manuscript submissions: 20 June 2024

https://sciforum.net/event/Pharmaceutics-3

15–30 November 2024 The 28th Electronic Conference on Synthetic Organic Chemistry (ECSOC-28)

Online

We cordially invite you to attend this event organized by Molecules (ISSN: 1420-3049, Impact Factor: 4.6). It will take place virtually on 15–30 November 2024, Central European Time.

Conference Chairs
Dr. Julio A. Seijas, Universidade de Santiago de Compostela, Spain

The Topics of Interest
S1. General Organic Synthesis;
S2. Chemistry of Bioorganic, Medicinal, and Natural Products;
S3. Microwave Assisted Synthesis;
S4. Polymer and Supramolecular Chemistry;
S5. Computational Chemistry.

Important Dates
Deadline for Abstract Submission: 1st July 2024
Notification of Acceptance: 25th July 2024

Guide for Authors
To submit your abstract, please click on the following link:
http://tinyurl.com/5xrjud5e

To register for the event, please click on the following link:
http://tinyurl.com/mr3njtn2

For details regarding Abstract Submission, Poster and Slide Submission, and Publication Opportunities, you may refer to the “Instructions for Authors” section:
http://tinyurl.com/23duymfv

For inquiries regarding submissions and sponsorship opportunities, please feel free to contact ecsoc@mdpi.com

We look forward to seeing you at the 28th Electronic Conference on Synthetic Organic Chemistry (ECSOC-28)

http://tinyurl.com/mr2c74fz

Conference Year
Conference Month
 

Upcoming Partner Conferences (0)

No conferences found for the selection.
Back to TopTop